Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal acquisition of Formulytica – Capital raising

Opal acquisition of Formulytica – Capital raising May 6, 2021 • Category • Author Name

Opal acquisition of Formulytica – Capital raising

Latest News

2025 AGM Notice of Meeting

November 28, 2025

2025 AGM Notice of Meeting

Read More
2025 Annual Report

November 25, 2025

2025 BioDiem Limited Annual Report

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions